transcatheter aortic valve implantation (tAVi) still presents complications: paravalvular leakage (pVL) and onset of conduction abnormalities leading to permanent pacemaker implantation. Our aim was testing a validated patient-specific computational framework for prediction of TAVI outcomes and possible complications. Twenty-eight TAVI patients (14 SapienXT and 14 CoreValve) were retrospectively selected. Pre-procedural CT images were post-processed to create 3D patientspecific implantation sites. The procedures were simulated with finite element analysis. Simulations' results were compared against post-procedural clinical fluoroscopy and echocardiography images. The computational model was in good agreement with clinical findings: the overall stent diameter difference was 2.6% and PVL was correctly identified with a post-processing algorithm in 83% of cases. Strains in the implantation site were studied to assess the risk of conduction system disturbance and were found highest in the patient who required pacemaker implantation. this study suggests that computational tool could support safe planning and broadening of tAVi. Transcatheter aortic valve implantation (TAVI) is an established treatment for patients with severe aortic stenosis (AS) who are deemed unsuitable for surgery 1-5. Since the first-in-man implantation in 2002 6 , TAVI technology has experienced a tremendous amount and pace of progress, thanks to developments in pre-procedural imaging assessment, operator experience, and engineering device research 7 , so that a treatment that was designed for high-risk patients only, is now shifting toward lower surgical risk case applications 8,9 with many companies presenting innovative valved stent designs to overcome most of the limitations of the first-generation TAVI devices 5,7,10. However, TAVI still presents complications, mainly related to device sizing and positioning. If oversized, the TAVI device might cause vascular injury, such as aortic dissection, perforation or rupture of the aortic annulus; 11,12 if undersized, it may present anchoring problems, embolization and paravalvular leakage (PVL), reported in 65-89% of cases 13,14. Conduction abnormalities commonly (12-35%) occur following TAVI 15-18 , leading to the need of permanent pacemaker (PPM) implantation, more frequently required with self-expandable devices (28% vs. 6% of balloon-expandable choices) 19 likely due to their material properties and larger sizes resulting in higher forces applied to the adjacent native conduction system 1,18,20. These complications highlight the importance of accurate interventional planning, appropriate device choice and correct patient selection. In this context, computational simulations, an already established tool to support engineering device development, could be useful, if integrated with a patient-specific approach, to support clinical decision making and introduce new technologies in clinical practice. Despite increasing acknowledgement of the usefulness of patient-specific computational modelling from...